BioVersys AG | Finanzwire

Basculer en Français

10108	Companies
207153	Keywords
137289	Articles
109796	Press releases

Home
Companies
BioVersys AG

BRIEF

published on 03/26/2025 at 07:05, 1 year ago

BioVersys Outlines 2024 Achievements and Financials

2024 Financials IPO Success BioVersys AG BV100 Trial Alpibectir Studies
PRESS RELEASE

published on 03/26/2025 at 07:00, 1 year ago

BIOVERSYS REPORTS CORPORATE HIGHLIGHS AND KEY FINANCIALS FOR THE FULL YEAR 2024
BioVersys AG reports corporate highlights and key financials for the full year 2024 including successful IPO on SIX Swiss Exchange, Phase 2 trial results, and financial activities

Financial Results Clinical Trials IPO Operating Income BioVersys AG
BRIEF

published on 03/19/2025 at 07:05, 1 year ago

First Patient Dosed in Alpibectir-Ethionamide TB Trial

Phase 2 Trial GSK Collaboration BioVersys Alpibectir-Ethionamide Tuberculosis
PRESS RELEASE

published on 03/19/2025 at 07:00, 1 year ago

FIRST EVER PATIENT DOSED WITH ALPIBECTIR-ETHIONAMIDE IN COMBINATION WITH FIRST-LINE TB DRUGS IN A 14-DAY PHASE 2 CLINICAL TRIAL
First patient dosed in 14-day Phase 2 clinical trial evaluating Alpibectir-Ethionamide with first-line TB drugs under BioVersys and GSK collaboration for pulmonary TB patients

GSK Phase 2 BioVersys Alpibectir-Ethionamide TB
BRIEF

published on 03/14/2025 at 07:05, 1 year ago

BioVersys Sets March 26 for Full-Year 2024 Financial Results Release

Financial Results Conference Call Biopharmaceutical Antibacterial Products BioVersys
PRESS RELEASE

published on 03/14/2025 at 07:00, 1 year ago

BIOVERSYS ANNOUNCES REPORTING DATE FOR FULL-YEAR 2024 FINANCIAL RESULTS AND EVENT DETAILS
BioVersys AG announces reporting date for full-year 2024 financial results and event details, including a conference call and webcast on March 26, 2025. The company focuses on developing novel antibacterial products for MDR bacteria

Financial Results Conference Call BioVersys AG Antibacterial Products MDR Bacteria
BRIEF

published on 03/10/2025 at 07:05, 1 year ago

BioVersys AG Announces Partial Exercise of Over-Allotment Option

Biopharmaceutical Company SIX Swiss Exchange Over-allotment Option BioVersys IPO Antibacterial Products
PRESS RELEASE

published on 03/10/2025 at 07:00, 1 year ago

Bioversys announces partial exercise of over-allotment option
BioVersys announces partial exercise of over-allotment option following successful IPO on the SIX Swiss Exchange, raising total gross proceeds of CHF76.7 million

Biopharmaceutical Company IPO Over-allotment Option BioVersys Multidrug-resistant Bacteria
BRIEF

published on 02/11/2025 at 07:05, 1 year 1 month ago

BioVersys Advances BV500 NTM Program with CF AMR Syndicate Support

Cystic Fibrosis BioVersys AG NTM Program LifeArc Support Ansamycin Chemistry
PRESS RELEASE

published on 02/11/2025 at 07:00, 1 year 1 month ago

BIOVERSYS SUCCESSFULLY ADVANCES BV500 NTM PROGRAM WITH CONTINUED SUPPORT FROM CF AMR SYNDICATE
BioVersys advances BV500 NTM program with continued support from CF AMR Syndicate, developing therapies for NTM lung disease in CF patients. Company focuses on antibacterial products against MDR bacteria

BioVersys BV500 NTM Program CF AMR Syndicate NTM Lung Disease MDR Bacteria

Accesswire

Published on 03/28/2026 at 01:00, 18 hours 58 minutes ago

Battery X Metals Announces Confidential Submission of Amended Draft Registration Statement with the U.S. Securities and Exchange Commission in Connection with Proposed U.S. National Securities Exchange Initial Public Offering
Published on 03/28/2026 at 00:55, 19 hours 3 minutes ago

Notification of Relevant Change to Significant Shareholder
Published on 03/28/2026 at 00:50, 19 hours 8 minutes ago

"Rise" Selected as NASA Artemis II Moon Mascot
Published on 03/27/2026 at 22:45, 21 hours 13 minutes ago

Caledonia Mining Corporation Plc - Notification of Relevant Change to Significant Shareholder
Published on 03/27/2026 at 22:30, 21 hours 28 minutes ago

Usha Resources Completes Extended Induced Polarization Survey at the Southern Arm Property

View all ACCESSWIRE

EQS Group

Published on 03/28/2026 at 10:05, 9 hours 52 minutes ago

Hisense Advances a Quiet Green Revolution in Home Entertainment
Published on 03/28/2026 at 08:56, 11 hours 1 minute ago

Turkiye Garanti Bankasi A.S.: Sale of Garanti Bank S.A. and our public disclosure dated 10.03.2026
Published on 03/28/2026 at 01:42, 18 hours 16 minutes ago

EQS-Adhoc: Raiffeisen Bank International AG: Agreement on the acquisition of Garanti BBVA Group Romania
Published on 03/27/2026 at 21:58, 21 hours 59 minutes ago

Kaufman & Broad SA: Availability of the Universal Registration Document 2025
Published on 03/27/2026 at 20:08, 23 hours 50 minutes ago

EQS-Adhoc: CECONOMY AG: Information on the ongoing public takeover process – uncertainty regarding FDI clearance in Austria

Les Echos

Published on 03/27/2026 at 19:06, 1 day ago

Mersen: Disclosure of trading own shares
Published on 03/27/2026 at 18:52, 1 day 1 hour ago

Crédit Agricole CIB announces the publication of its 2025 Universal Registration Document
Published on 03/27/2026 at 18:40, 1 day 1 hour ago

2026 share capital increase reserved for members of the Saint-Gobain Group employee savings plan
Published on 03/27/2026 at 17:53, 1 day 2 hours ago

Publication of Carrefour's 2025 Universal Registration Document
Published on 03/27/2026 at 17:45, 1 day 2 hours ago

PUBLICATION OF THE UNIVERSAL REGISTRATION DOCUMENT FISCAL YEAR 2025

View all LES ECHOS COMFI WIRE